Key result
Cardiovascular pharmacotherapy during pregnancy and lactation requires tailored considerations and drug-specific management strategies.
Answers are grounded in this paper and cite their sources.
Summarizes clinical recommendations for cardiovascular pharmacotherapy during pregnancy and lactation, highlighting maternal and fetal safety considerations.
Table 2 summarizes the recommendations regarding the use of cardiovascular drugs during pregnancy and lactation.
No takes yet. Share an insight, caveat, or question.
Qasqas et al. (2004) studied this question. Cardiovascular drug use during pregnancy and lactation requires specific pharmacotherapeutic considerations and recommendations.
Synapse has enriched 10 related papers. Consider them for comparative context: